Recurrent cutaneous hyalohyphomycosis secondary to Purpureocillium lilacinum in an immunocompetent individual.

Autor: McGeachie DL; Dermatology Department, Townsville University Hospital, Douglas, Townsville, QLD, Australia., Boyce AE; Dermatology Department, Townsville University Hospital, Douglas, Townsville, QLD, Australia., Miller RM; Selassie House, Townsville, QLD, Australia.
Jazyk: angličtina
Zdroj: The Australasian journal of dermatology [Australas J Dermatol] 2021 Aug; Vol. 62 (3), pp. e411-e413. Date of Electronic Publication: 2021 Jun 25.
DOI: 10.1111/ajd.13657
Abstrakt: Purpureocillium lilacinum, previously classified as Paecilomyces lilacinus, is a ubiquitous hyaline hyphomycete considered to be an emerging opportunistic human pathogen that is resistant to traditional antifungal agents. This case report describes what is to our knowledge the only published case of P. lilacinum recrudescence in an immunocompetent host despite initial best-practice treatment with 10 weeks of voriconazole and surgical excision.
(© 2021 The Australasian College of Dermatologists.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje